OS Therapies Agrees to Acquire All Listeria Monotygenes-based Immuno-Oncology Programs and IP Assets from Ayala Pharmaceuticals, Adding Phase 2 Lung Cancer and Phase 1 Prostate Cancer Programs to Pipeline
January 29, 2025
Host Jonathan Miller interviews CFO: Jason Keyes, who's committed to harnessing the power of the immune system by using Equillium's services, to transform patient care.
January 29, 2025
January 14, 2025
July 16, 2024
July 9, 2024